Related by context. All words. (Click for frequent words.) 72 cyclophosphamide FC 69 FOLFOX6 chemotherapy regimen 69 capecitabine Xeloda 69 trastuzumab Herceptin R 67 mitoxantrone plus 67 docetaxel Taxotere R 67 Peginterferon alfa 2b 67 ® lenalidomide 67 alfa 2a 67 Xeloda ® 67 Initiates Enrollment 66 cyclophosphamide doxorubicin vincristine 66 Budesonide foam crofelemer 66 plus prednisone 66 refractory chronic lymphocytic 66 Romiplostim 66 Taxotere docetaxel 66 IMiDs ® 66 Xelox 66 evaluating tivozanib 66 Aflibercept 65 baminercept 65 AVASTIN 65 R sorafenib tablets 65 docetaxel Taxotere 65 5 FU leucovorin 65 Mg Usa 65 TO AVOID PREGNANCY WHILE 65 galiximab 65 INSPIRE Trial Phase III 65 erlotinib Tarceva ® 65 bortezomib Velcade R 65 ® bortezomib 65 thalidomide Thalomid 65 Dabigatran etexilate 65 sorafenib Nexavar R 65 Xeloda capecitabine 65 Crofelemer budesonide foam 65 interferon gamma 1b 64 progressive metastatic prostate 64 azilsartan medoxomil 64 plus prednisone prednisolone 64 Gemzar gemcitabine 64 sorafenib Nexavar 64 erlotinib Tarceva R 64 oral chemotherapeutic agent 64 anthracycline taxane 64 Tarceva TM 64 infliximab monotherapy 64 LymphoStat B belimumab 64 IMiDs 64 dasatinib Sprycel ® 64 Emtriva Viread 64 Nexavar sorafenib 64 chemotherapy FOLFOX 64 Mg Uk 64 lenalidomide Revlimid R 64 humanized therapeutic 64 standard chemotherapy regimen 64 relapsed MM 64 adalimumab Humira 64 Epratuzumab 64 DEB# 64 Velcade bortezomib 63 Fludara ® 63 Platinol ® cisplatin 63 cyclophosphamide methotrexate 63 ACTEMRA TM 63 weekly subcutaneous injections 63 ribavirin RBV 63 Copegus ribavirin 63 MAGE A3 ASCI 63 RoACTEMRA 63 Rituxan rituximab 63 Multaq dronedarone 63 Hydrochlorothiazide Tablets 63 lumiliximab 63 SPRYCEL ® 63 Vidaza ® 63 Azacitidine 63 Pazopanib 63 vapreotide acetate 63 metaglidasen 63 ritonavir boosted 63 Pegasys peginterferon alfa 2a 63 Campath alemtuzumab 63 alpha 2b 63 memantine HCl 63 prednisone CHOP 63 refractory CLL 63 Femara letrozole 63 potent triglyceride lowering 63 docetaxel Injection Concentrate 63 Bayer HealthCare Onyx Pharmaceuticals 63 HGS# 63 Folfox 63 metastatic colorectal carcinoma 63 irinotecan doxorubicin oxaliplatin paclitaxel 63 dacarbazine DTIC 63 PEGINTRON TM 63 Peg IFN 63 docetaxel Taxotere ® 63 sulfonylurea glimepiride 63 mapatumumab 63 Temodar ® 63 tinidazole 63 sorafenib tablets 63 R# #mg BID 62 brand ciclesonide HFA 62 Meets Primary Endpoint 62 virus HCV protease inhibitor 62 FUSILEV enhances 62 pharmacogenomic translational research 62 Navelbine ® 62 Targretin capsules 62 elotuzumab 62 pegylated interferon alpha 62 pegylated liposomal doxorubicin 62 octreotide acetate 62 non nucleoside inhibitor 62 chronic idiopathic thrombocytopenic purpura 62 tenofovir emtricitabine 62 etanercept Enbrel 62 plus dexamethasone 62 Peginterferon 62 Naive Patients 62 cortisol synthesis 62 adenosine injection 62 CHOP cyclophosphamide doxorubicin vincristine 62 sargramostim 62 Arranon 62 FEMALES SHOULD BE ADVISED 62 Telik logo TELINTRA 62 bone marrow reticulin deposition 62 Pruvel TM 62 Camptosar ® 62 receiving VELCADE 62 Neulasta R 62 estramustine 62 infusional 5-FU/LV 62 ZOLINZA 62 gemcitabine carboplatin 62 HMG CoA reductase inhibitors 62 myelodysplastic myeloproliferative diseases 62 Taxotere chemotherapy 62 XL# anticancer compounds 62 interferon ribavirin 62 glycoprotein IIb IIIa inhibitor 62 naïve HCV 62 FOLFIRI chemotherapy 62 anthracyclines taxanes 62 paclitaxel Taxol ® 62 cisplatin gemcitabine 62 PEG INTRON R 62 Elotuzumab 62 5 fluorouracil leucovorin 62 Vidaza R 62 AEGR 62 CYT# potent vascular disrupting 62 kidney urologic 62 thetreatment 62 lenalidomide Revlimid 62 pioglitazone HCl 62 beta 1a 62 Amgen Neulasta R 62 Pertuzumab 62 Irinotecan 62 Pegasys ® 61 metformin sulfonylurea 61 Fludarabine 61 Bosutinib 61 Levoleucovorin 61 peginterferon alfa 2b 61 COLAZAL R 61 aflibercept VEGF Trap 61 recurrent metastatic ovarian cancer 61 gemtuzumab ozogamicin 61 de novo kidney transplant 61 ADP receptor antagonist 61 brivanib 61 CVP cyclophosphamide vincristine 61 Fludara 61 non resectable metastatic 61 Ribavirin causes 61 ritonavir boosted atazanavir 61 abacavir lamivudine 61 pegylated interferon alfa 2a 61 PEGylated docetaxel 61 rheumatoid arthritis psoriatic arthritis 61 aromatase inhibitor AI 61 demonstrated antitumor activity 61 adriamycin 61 Annamycin 61 gemcitabine Gemzar ® 61 oral rivaroxaban 61 MIRAPEX ER 61 Doxil ® 61 phase III isavuconazole 61 developing Bicifadine serotonin 61 docetaxel chemotherapy 61 zoledronic acid Reclast 61 stage IIIb IV 61 PI3K/Akt pathway inhibitor 61 aspirin clopidogrel 61 gemcitabine chemotherapy 61 venlafaxine ER 61 evaluating Xcytrin 61 GW# [003] 61 Raptiva ® 61 HGS ETR1 mapatumumab 61 Initiates Phase II 61 SUTENT ® 61 CYP#A# CYP#D# 61 Tasigna nilotinib 61 follicular Non Hodgkin 61 5mg #mg 61 Intravitreal 61 Completes Patient Enrollment 61 Zenvia ™ 61 rufinamide 61 commercializes implantable 61 gemcitabine cisplatin 61 pregabalin Lyrica 61 iniparib 61 IGF 1R inhibitor 61 oral levofloxacin 61 Tarceva erlotinib 61 neutropenia dehydration dyspnea 61 % pramoxine HCl 61 IMiDs R 61 albiglutide 61 reslizumab 61 bendamustine 61 non splenectomized 61 COLAZAL ® 61 Relapsed Refractory 61 Oxaliplatin 61 dasatinib Sprycel 61 Vytorin combines 61 relapsed acute lymphoblastic 61 telaprevir dosed 61 oral prodrug 61 alpha 2a 61 everolimus tablets 61 Pemetrexed 61 acyclovir Lauriad R 60 Omacetaxine 60 Ziprasidone 60 gemcitabine Gemzar 60 recurrent glioblastoma multiforme 60 doxorubicin cyclophosphamide 60 novel VDA molecule 60 low dose cytarabine 60 REMINYL ® 60 cisplatin vinorelbine 60 Kit CD# positive 60 Myelodysplastic Syndrome MDS 60 neratinib 60 EOquin TM phase 60 sunitinib malate 60 humanized interleukin 6 60 Sutent sunitinib 60 Arzerra ofatumumab 60 pegylated interferon alfa 60 Alimta pemetrexed 60 blinded randomized placebo controlled 60 Afinitor everolimus 60 sorafenib Nexavar ® 60 Plaquenil 60 rilonacept 60 relapsed multiple myeloma 60 PEGylated anti 60 q8h 60 chemotherapy cisplatin 60 candesartan cilexetil 60 5 FU capecitabine 60 AAG geldanamycin analog 60 Combination REOLYSIN R 60 oropharyngeal candidiasis OPC 60 monoclonal antibody IgG1 Mab 60 undergoing elective percutaneous 60 irbesartan 60 CHOP chemotherapy 60 ENL recurrence 60 evaluating picoplatin 60 refractory indolent non 60 diarrhea vomiting nausea 60 VEGFR2 inhibitor 60 lintuzumab SGN 60 arsenic trioxide injection 60 Noxafil 60 ALN HPN 60 aripiprazole Abilify 60 myocardial infarction ventricular fibrillation 60 interferon alfa 2a 60 hyperphenylalaninemia HPA due 60 nilotinib Tasigna ® 60 8mg/kg 60 pamidronate 60 somatostatin analog 60 relapsed leukemia 60 methotrexate MTX 60 oral antiviral 60 cetuximab Erbitux R 60 radiotherapy RT 60 ergot derivatives 60 Sapacitabine 60 #mg #mg #mg [003] 60 HCl capsules 60 angiotensin receptor blocker ARB 60 phase IIb trial 60 lenalidomide dexamethasone 60 headache nasopharyngitis 60 constipation predominant irritable bowel 60 Cimzia TM 60 Copegus R 60 mTOR inhibitor 60 Certolizumab pegol 60 MGd 60 Taxol paclitaxel 60 Vincristine 60 alvespimycin 60 R rilonacept Injection 59 metastatic hormone refractory 59 Teriflunomide 59 certolizumab 59 FOLFOX chemotherapy 59 relapsed refractory multiple myeloma 59 TORISEL 59 3TC lamivudine Epivir 59 markets COLAZAL 59 bevacizumab Avastin R 59 NS5B polymerase 59 Lenalidomide 59 previously untreated follicular 59 oral anti arrhythmic 59 Pharmacokinetics PK 59 leukemia CLL 59 Leukine ® 59 Topotecan 59 pertuzumab 59 rituximab refractory follicular 59 cytarabine daunorubicin 59 refractory cutaneous T 59 Ph + acute lymphoblastic 59 clopidogrel Plavix 59 Tekamlo 59 Chronic Lymphocytic Leukemia CLL 59 ziprasidone Geodon 59 hormone refractory metastatic prostate 59 PLX STROKE targeting 59 hoFH 59 OMP #R# 59 prednisone prednisolone plus 59 potent CYP#A# inhibitors 59 TRIOLEX HE# APOPTONE HE# 59 paclitaxel Taxol R 59 solid tumors ZYBRESTAT 59 dextromethorphan quinidine 59 TNF Tumor Necrosis Factor 59 interferon alfa 2b 59 budesonide pMDI 59 Initiate Phase 59 refractory myeloma 59 Oral Fingolimod 59 Gleevec imatinib mesylate 59 evaluating T DM1 59 Romidepsin 59 REVLIMID ® 59 retinal vein occlusion induced 59 post herpetic neuralgia PHN 59 Vaprisol 59 Rigel R# 59 Pharmion Vidaza 59 ribavirin therapy 59 MKC# MT 59 oral deforolimus 59 R ferumoxytol Injection 59 Personalized Immunotherapy 59 basal bolus regimen 59 receiving INTRON 59 idiopathic thrombocytopenic purpura ITP 59 Transgenomic Pharmacogenomics Services 59 pan histone deacetylase 59 serotonin norepinephrine reuptake inhibitor 59 comparator arm 59 alfuzosin 59 melphalan prednisone 59 aspirin heparin 59 relapsed indolent NHL 59 Phase Ib IIa 59 Empatic ™ 59 TAXOTERE R 59 Randomized Double blind 59 TTF Therapy 59 dexamethasone Decadron 59 leukemia AML 59 Cytarabine 59 Prescription acetaminophen 59 Vidaza azacitidine 59 risperidone Risperdal 59 2 methoxyestradiol 59 inhalations twice 59 ocular formulation 59 Darunavir 59 DOXIL 59 CAELYX 59 xanthine oxidase inhibitor 59 Genentech Rituxan 59 multiple myeloma MM 59 plus gemcitabine 59 evaluating mipomersen 59 oral Janus kinase 59 relapsing remitting MS RRMS 59 peginterferon alfa 2a Pegasys 59 Degarelix 59 Obatoclax 59 Bevacizumab Avastin 59 capecitabine Xeloda R 59 adefovir dipivoxil 59 lamotrigine Lamictal 59 generation DACH Platinum 59 lapatinib Tykerb 59 inhalation powder 59 combines bupropion 58 TAXUS Element Paclitaxel Eluting 58 regorafenib 58 Bendamustine 58 PEGylated irinotecan 58 Panzem R NCD 58 TELINTRA 58 Major Depressive Disorder MDD 58 basiliximab 58 intra arterial chemotherapy 58 receptor tyrosine kinase inhibitor 58 Evoltra ® 58 HGS ETR2 58 treatment naïve genotype 58 Atripla combines 58 receiving prophylactic anticoagulation 58 selective estrogen receptor modulator 58 etoposide 58 TELINTRA R 58 fludarabine cyclophosphamide 58 metastatic malignant 58 peginterferon alpha 2a 58 IAP inhibitor 58 orally administered inhibitor 58 5 HT2A inverse 58 alefacept 58 paclitaxel Taxol 58 DOXIL ® 58 prokinetic agent 58 rash pruritus nausea 58 sapacitabine CYC# 58 vincristine doxorubicin 58 including cyclosporine methotrexate 58 AKT inhibitor 58 #I TM# 58 recurrent malignant glioma 58 fostamatinib 58 lenalidomide Revlimid ® 58 MabThera rituximab 58 VELCADE melphalan 58 pegylated interferons 58 alpha interferons 58 nucleoside analog 58 teriflunomide 58 Zarnestra 58 Aztreonam lysine 58 Ovitrelle R Serostim 58 anastrazole 58 boosted protease inhibitor 58 metformin HCl 58 refractory NSCLC 58 Mitoxantrone 58 Cloretazine 58 RTP #i 58 imatinib Gleevec ® 58 TEMODAL 58 BMS # 58 syndrome IBS 58 metastatic pancreatic 58 evaluating satraplatin 58 bevacizumab Avastin ® 58 CLL SLL 58 visilizumab 58 Enzastaurin 58 Navelbine 58 Novantrone 58 EGFR expressing mCRC 58 sertraline Zoloft 58 desvenlafaxine succinate 58 dacarbazine 58 Helicobacter pylori eradication 58 advanced metastatic renal 58 recombinant PSMA vaccine 58 multicenter Phase III 58 LEVAQUIN ® 58 immune thrombocytopenic purpura 58 Diffuse Large B 58 paroxetine Paxil 58 Nexavar tablets 58 oral dual endothelin 58 EPIVIR 58 alkylating agent 58 sarcoma melanoma 58 esophageal candidiasis 58 leukotriene receptor antagonist 58 Nilotinib 58 secondary hyperparathyroidism SHPT 58 Orally administered 58 Cloretazine ® 58 pralatrexate injection folate analogue 58 rosuvastatin Crestor 58 refractory colorectal cancer 58 Myelofibrosis 58 corticosteroid dexamethasone 58 Novartis Afinitor 58 Tiuxetan 58 Phase Ib II 58 Luveris R Ovidrel R 58 MabCampath 58 investigational protease inhibitor 58 Amrubicin 58 BRAF inhibitor 58 pharmacologically active isomer 58 lymphoid malignancies 58 alendronate Fosamax 58 carboplatin paclitaxel 58 tenofovir Viread 58 PEGylated Fab fragment 58 ceftazidime 58 TMC# r 58 FOLOTYN ® 58 Pegasys plus Copegus 58 evaluating adecatumumab 58 diabetic neuropathic pain 58 treatment naive genotype 58 folinic acid 58 HCV NS5B polymerase 57 CK # administered 57 neutropenic sepsis 57 Contrave# 57 Hycamtin ® 57 oral ridaforolimus 57 maximally tolerated dose 57 generation Hsp# inhibitor 57 cisplatin carboplatin 57 Hypertensive adverse reactions 57 chemotherapeutic regimen 57 bortezomib Velcade 57 virologically suppressed 57 RLAI 57 doxorubicin Adriamycin 57 CML CP 57 Fluorouracil 57 Kepivance 57 Novel Oral 57 trastuzumab Herceptin ® 57 #mg/#mg 57 idarubicin 57 unfractionated heparin UFH 57 phase IIb study 57 Pegylated interferon 57 irinotecan cisplatin 57 sunitinib Sutent ® 57 Xanafide 57 pain palliation 57 Entereg R 57 nucleoside naive 57 Panzem NCD 57 tramiprosate Alzhemed TM 57 Clindamycin 57 benign prostatic hypertrophy BPH 57 Adenoscan R 57 Oral NKTR 57 Pharma Merck Serono 57 nefazodone 57 recurrent metastatic 57 primary hypercholesterolemia 57 cutaneous T 57 Juvenile Idiopathic Arthritis JIA 57 TRANSDUR ® 57 ORENCIA R 57 Selzentry Celsentri 57 PRT# 57 deCODE AF TM 57 multi kinase inhibitor 57 oropharyngeal candidiasis 57 Telintra 57 R bendamustine hydrochloride 57 HCV RESPOND 2 57 Kuvan R 57 Phase Ib clinical 57 Paxil paroxetine 57 indinavir Crixivan 57 MEK Inhibitor 57 ARB telmisartan 57 fenofibric acid 57 PNP inhibitor 57 chlorambucil 57 recombinant interferon 57 Atypical Hemolytic Uremic Syndrome 57 Seliciclib 57 axitinib 57 BCG refractory 57 Combination therapy 57 Epothilone D 57 Methylnaltrexone 57 Phase IIb randomized 57 piperacillin tazobactam 57 biologic DMARD 57 ALN VSP Phase 57 Pegylated Interferon 57 Flu Cy 57 QVAR ® 57 Paraplatin ® 57 intravesical infusion therapy 57 cetuximab Erbitux ® 57 olanzapine Zyprexa 57 non constipating irritable 57 REVLIMID R 57 Sudhir Agrawal D.Phil 57 Tasimelteon 57 coronary stent merged 57 CIMZIA R 57 PREZISTA r 57 known dihydropyrimidine dehydrogenase 57 Immune Reconstitution Syndrome 57 fludarabine phosphate 57 saquinavir ritonavir 57 clozapine Clozaril 57 multicenter Phase II 57 mycophenolate mofetil 57 valsartan amlodipine 57 finasteride Proscar 57 subependymal giant cell 57 metastatic androgen independent 57 Phase 1b clinical trials 57 rituximab Rituxan 57 Diovan Exforge Tekturna Zelnorm 57 lomitapide 57 APTIVUS 57 Celebrex celecoxib 57 #mg ritonavir 57 Treanda 57 INTEGRILIN R 57 anti muscarinic 57 vinca alkaloid 57 cell lymphoma CTCL 57 pegylated alpha interferon 57 Cyclophosphamide 57 Abiraterone acetate 57 ACAPODENE TM 57 liposomal doxorubicin 57 liposomal formulation 57 PSN# [001] 57 temozolomide TMZ 57 Pegasys R 57 Cryopyrin Associated Periodic Syndromes 57 mg RDEA# 57 gadobutrol 57 IV Busulfex 57 p# MAP kinase inhibitor 57 ATRA IV 57 non hodgkin lymphoma 56 azathioprine monotherapy 56 tazobactam 56 initiated Phase Ib 56 including eniluracil ADH 56 epirubicin cyclophosphamide 56 systemic juvenile idiopathic 56 Saforis 56 indolent NHL 56 Asacol HD 56 refractory gout 56 Clofarabine 56 cediranib 56 haematologic malignancies 56 small molecule glucokinase 56 By JENNIFER LEARN 56 Myozyme alglucosidase alfa 56 PDX pralatrexate 56 malignant mesothelioma Alfacell 56 VIIBRYD 56 overactive bladder syndrome 56 Phase 1b trial 56 indolent follicular non 56 relapsed CLL 56 rifabutin 56 IIIa inhibitor 56 either acutely decompensated 56 Lupus Nephritis 56 ZACTIMA 56 FASLODEX 56 Pivotal Study 56 plus Copegus R 56 antiretroviral medicinal 56 systemic antifungal 56 Novartis Trileptal 56 Tekturna HCT 56 pediatric acute lymphoblastic 56 RECORD1 56 Cancidas 56 administered concomitantly 56 mcg QD 56 Temodar temozolomide 56 CINQUIL 56 daunorubicin 56 related DHFR inhibitors 56 follicular lymphoma FL 56 meropenem 56 romiplostim 56 5-fluorouracil/leucovorin 56 relapsed myeloma 56 Soft Tissue Sarcoma 56 Afatinib 56 investigational humanized monoclonal antibody 56 taxane chemotherapy 56 includes TOLAMBA TM 56 mGluR2 positive 56 PEG IFN 56 cytarabine 56 intranasal formulation 56 Randomized Phase 56 non metastatic osteosarcoma 56 RezularTM 56 THR beta agonist 56 MDS AML 56 MIVI III 56 MIRAPEX 56 rhIGF-I/rhIGFBP-3 56 deforolimus 56 evaluating Actimmune 56 bupropion SR 56 rituximab refractory 56 SYNERGY Stent 56 iloprost synthetic compound 56 oblimersen 56 mirtazapine 56 Gleevec imatinib 56 5-FU/LV 56 Onco TCS 56 CTA# Injection 56 Rituxan MabThera 56 placebo controlled Phase III 56 mcg BID 56 BRIM2 56 pan HDAC inhibitor 56 plus DOXIL 56 Myocet 56 FOLFIRI 56 Gleevec resistant 56 TMP SMX 56 cardiotoxic 56 acute mania 56 potentially hepatotoxic 56 LHRH analogues 56 metastatic gastric 56 CIMZIA TM certolizumab pegol 56 bevirimat Study 56 Abrupt discontinuation 56 LHRH receptor positive 56 Multiple Myeloma MM 56 AGILECT R 56 reteplase 56 asymptomatic metastatic 56 HeFH 56 nucleotide analog 56 vaccinated PNH patients 56 invasive candidiasis 56 systemic anaplastic large 56 antidepressants fluoxetine 56 histone deacetylase HDAC inhibitor 56 hour bronchodilation 56 beta2 agonist 56 HER2 positive metastatic breast 56 refractory AML 56 Cetuximab Erbitux 56 NATRECOR ® 56 lesinurad 56 ramipril Altace 56 CVP chemotherapy 56 Clonicel 56 pyrazinamide 56 dual endothelin receptor antagonist 56 Serostim ® 56 severe hypersensitivity reactions 56 REGN# 56 fumarate 56 daily Infergen 56 radioimmunotherapeutic agent 56 nab paclitaxel 56 Ciclesonide 56 paclitaxel carboplatin 56 forodesine 56 cinacalcet 56 MyVax R 56 APTIVUS r 56 fosbretabulin 56 denileukin diftitox 56 smoldering multiple myeloma 56 idiopathic thrombocytopenic purpura 56 atorvastatin Lipitor 55 KAPIDEX 55 TREANDA 55 Imprime PGG 55 standard chemotherapy regimens 55 drugs cough suppressant 55 generation purine nucleoside 55 Treanda bendamustine 55 testing huN# DM1 55 PMX # heptagonist 55 relapsed mantle 55 ara C 55 inhaled corticosteroid ICS 55 CRESTOR #mg 55 ezetimibe Zetia 55 MCSP respectively 55 Platinol ® 55 refractory ovarian cancer 55 BEXXAR 55 nucleoside analogs 55 hydroxymethyl coenzyme 55 Ophena TM 55 Hopper costarred 55 Quinamed 55 zalutumumab 55 inhaled antibiotic 55 symptomatic BPH 55 relapsed refractory aggressive 55 small molecule chemotherapeutic 55 micafungin 55 TNF antagonist 55 highly selective inhibitor 55 Alagebrium 55 Phase III multicenter 55 darunavir ritonavir 55 migraine headaches AZ 55 pomalidomide 55 vinorelbine 55 Deforolimus 55 relapsed ovarian cancer 55 levoleucovorin 55 GetGoal Phase III 55 Phase III metastatic melanoma 55 lung pancreatic 55 immune thrombocytopenic purpura ITP 55 multicenter placebo controlled 55 Alocrest 55 Pradefovir 55 RG# ITMN 55 evaluating REVLIMID 55 Philadelphia Chromosome Positive 55 antiretroviral naive 55 exocrine pancreatic insufficiency EPI 55 Elacytarabine 55 HSP# inhibitor 55 undergoing hematopoietic stem 55 Carboplatin 55 investigational monoclonal antibody 55 systemic corticosteroid 55 RITUXAN 55 steroid prednisone 55 Augment Injectable 55 JAK inhibitor 55 Ozarelix 55 subcutaneous formulation 55 Phase IIIb study 55 MabThera Rituxan 55 platelet aggregation inhibitors 55 AVE# 55 PEG SN# 55 REVLIMID lenalidomide 55 selective phosphodiesterase 55 riociguat 55 abatacept Orencia 55 temsirolimus Torisel 55 OMP #M# 55 class mGluR5 inhibitor 55 NMIBC 55 null responder HCV 55 cisplatin chemotherapy 55 macrolide antibiotic 55 Proxinium TM 55 IBS C 55 % hydrocortisone acetate 55 GSK# [002] 55 PORxin TM platforms 55 systemic lupus erythematosus rheumatoid 55 Octreolin 55 mRCC 55 mg QD 55 hypereosinophilic syndrome 55 rilonacept Injection 55 refractory acute promyelocytic 55 #mg doses [002] 55 paclitaxel chemotherapy 55 AIR CF1 55 Decitabine 55 cell carcinoma RCC 55 Curis collaborator Genentech 55 Testosterone MDTS R 55 subcutaneously administered 55 EFAPROXYN 55 Fovea Pharmaceuticals subsidiary 55 refractory acute myeloid 55 pegfilgrastim 55 Dual Opioid 55 defibrillator CRT D 55 opioid induced bowel dysfunction 55 terfenadine 55 herpetic keratitis 55 echinocandin 55 vitamin B# folic acid 55 catheter occlusion 55 myelofibrosis polycythemia vera 55 mycophenolate mofetil MMF 55 peripheral sensory neuropathy 55 secondary hyperparathyroidism 55 active comparator 55 enzastaurin 55 registrational Phase 55 DepoCyt ® Abelcet ® 55 immunomodulatory therapy 55 GEM OS2 55 metastatic sarcoma 55 evaluating bavituximab 55 retinal thrombosis hemorrhages 55 Leukemia AML 55 INVANZ 55 Letairis ambrisentan 55 Chronic lymphocytic leukemia CLL 55 MKC# MKC# PP 55 Zavesca R 55 cyclophosphamide doxorubicin 55 metastatic CRC 55 tyrosine kinase inhibitor 55 personalized immunotherapy 55 specific CCR9 antagonist 55 venlafaxine XR 55 Albuferon TM 54 nevirapine Viramune 54 AVOREN 54 FOLFIRI alone 54 DU #b 54 4mg/kg 54 chemoradiation therapy 54 gastrointestinal toxicities 54 ORAL Solo 54 platelet inhibitor 54 Luteinizing Hormone Releasing Hormone 54 anthracycline derivative 54 Acute Ischemic Stroke 54 atrial fibrillation budiodarone ATI 54 mg q#h 54 ALGRX 54 EOquin TM 54 Val HeFT 54 Idec Roche Takeda 54 BAY #-# 54 investigational HCV polymerase 54 gastrointestinal stromal tumor GIST 54 Diabetic Macular Edema DME 54 mg TID 54 macroglobulinemia 54 refractory chronic myeloid 54 Pathway Inhibitor 54 CHAMPION PCI 54 omacetaxine mepesuccinate 54 ISENTRESS 54 Abbott HUMIRA 54 dose dexamethasone 54 orally inhaled migraine 54 mg BID 54 immune modulating 54 IL# PE#QQR 54 phase Ib 54 occlusion PAO 54 anti arrhythmic 54 Pivotal Trial 54 Platinol 54 ReoPro 54 anti angiogenic agents 54 ug dose 54 familial amyloidotic polyneuropathy FAP 54 EXPLORE Xa 54 Study Evaluating 54 diabetic gastroparesis 54 integrin inhibitor 54 LHRH agonists 54 EDEMA3 54 dopamine partial agonist 54 fallopian tube cancers 54 VAPRISOL 54 administered subcutaneously 54 monoclonal antibody conjugated 54 relapsed Acute Myeloid